Related Experiment Videos
[Expression of genes for metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis]
Abstract:
Using real-time polymerase chain reaction (RT-PCR), we measured mRNA amounts of matrix metalloproteinases (MMPs): MMP-1, MMP-2, MMP-9, and MMP-12 genes in psoriatic lesions and unaffected skin of the same patients. We observed significant (about 15-fold) increase in the expression level of matrix metalloproteinase MMP-1 and MMP-12 genes associated with psoriasis. The results of our studies of MMP gene expression in cultured primary human keratinocytes treated with interleukin (IL-17) have shown upregulation of MMP gene expression both in cultured keratinocytes and in psoriatic skin lesions. Therefore, upregulation of MMP genes in the skin affected by psoriasis could result from IL-17 effects on skin cells.
Insights
Psoriasis is linked to increased matrix metalloproteinase (MMP) gene expression, particularly MMP-1 and MMP-12. Interleukin-17 (IL-17) may drive this upregulation in skin cells, offering insights into psoriasis pathogenesis.
Area of Science:
- Dermatology and Molecular Biology
Context:
- Psoriasis is a chronic inflammatory skin condition.
- Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and inflammation.
Purpose:
- To investigate the expression levels of specific MMP genes (MMP-1, MMP-2, MMP-9, MMP-12) in psoriatic skin lesions compared to unaffected skin.
- To explore the role of Interleukin-17 (IL-17) in regulating MMP gene expression in keratinocytes and psoriatic skin.
Summary:
- Real-time polymerase chain reaction (RT-PCR) revealed significantly increased mRNA levels (approximately 15-fold) for MMP-1 and MMP-12 genes in psoriatic lesions.
- Studies on cultured human keratinocytes showed that IL-17 treatment upregulates MMP gene expression.
- These findings suggest that IL-17 contributes to the elevated MMP gene expression observed in psoriasis-affected skin.
Impact:
- Provides molecular insights into the pathogenesis of psoriasis.
- Identifies potential therapeutic targets by highlighting the role of MMPs and IL-17 in psoriatic skin.
- Contributes to understanding the inflammatory mechanisms underlying skin diseases.